Results 111 to 120 of about 765,049 (358)

Pathogenesis of systemic sclerosis associated interstitial lung disease

Journal of Scleroderma and Related Disorders, 2020
Systemic sclerosis is an autoimmune disease leading to vasculopathy and fibrosis of skin and internal organs. Despite likely shared pathogenic mechanisms, the patterns of skin and lung fibrosis differ.
S. Nihtyanova, C. Denton
semanticscholar   +1 more source

Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease [PDF]

, 2016
Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung ...
Amoroso, Daria, Barbano, Biagio, DI PAOLO, Marcello, Gigante, Antonietta, Palange, Paolo, Romaniello, Antonella, Rosato, Edoardo, Tallerini, Gaia   +7 more
core   +1 more source

Seeing inside the Body Using Wearable Sensing and Imaging Technologies

Advanced Healthcare Materials, EarlyView.
This review explores wearable technologies for noninvasive internal health monitoring. It categorizes approaches into indirect sensing (e.g., bioelectrical and biochemical signals) and direct imaging (e.g., wearable ultrasound and EIT), highlighting multimodal integration and system‐level innovation toward personalized, continuous healthcare.
Sumin Kim, Seunghun Han, Sehwan Park, Jahyun Koo   +3 more
wiley   +1 more source

A persistent variant telomere sequence in a human pedigree

Nature Communications
The telomere sequence, TTAGGG, is conserved across all vertebrates and plays an essential role in suppressing the DNA damage response by binding a set of proteins termed shelterin. Changes in the telomere sequence impair shelterin binding, initiate a DNA
Angela M. Hinchie, Samantha L. Sanford, Kelly E. Loughridge, Rachel M. Sutton, Anishka H. Parikh, Agustin A. Gil Silva, Daniel I. Sullivan, Pattra Chun-On, Matthew R. Morrell, John F. McDyer, Patricia L. Opresko, Jonathan K. Alder   +11 more
doaj   +1 more source

COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome [PDF]

, 2023
A. Laneri, Stefania Cerri, G. Della Casa, Antonio Moretti, Andreina Manfredi, Marco Sebastiani, Enrico Clini, Carlo Salvarani   +7 more
openalex   +1 more source

Drug-Induced Interstitial Lung Disease: A Systematic Review

Journal of Clinical Medicine, 2018
Background: Drug-induced interstitial lung disease (DIILD) occurs as a result of numerous agents, but the risk often only becomes apparent after the marketing authorisation of such agents.
S. Skeoch, N. Weatherley, A. Swift, A. Oldroyd, C. Johns, C. Hayton, A. Giollo, J. Wild, J. Waterton, M. Buch, K. Linton, I. Bruce, C. Leonard, S. Bianchi, N. Chaudhuri   +14 more
semanticscholar   +1 more source

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference [PDF]

, 2010
The response characteristics of the 6 minute walk test (6MWT) in studies of idiopathic pulmonary fibrosis (IPF) are only poorly understood, and the change in walk distance that constitutes the minimum important difference (MID) over time is ...
Behr, Jürgen, Brown, Kevin K., du Bois, Roland M., King, Talmadge E., Raghu, Ganesh, Swigris, Jeffrey J., Wamboldt, Frederick S.   +6 more
core   +1 more source

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao, Chandan Kumar Mandal, Fernando Patolsky   +2 more
wiley   +1 more source

Developments in lung transplantation over the past decade

European Respiratory Review, 2020
With an improved median survival of 6.2 years, lung transplantation has become an increasingly acceptable treatment option for end-stage lung disease. Besides survival benefit, improvement of quality of life is achieved in the vast majority of patients ...
Sophie C. van der Mark, Rogier A.S. Hoek, Merel E. Hellemons   +2 more
doaj   +1 more source

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

New England Journal of Medicine, 2018
BACKGROUND Given the phenotypic similarities between rheumatoid arthritis (RA)–associated interstitial lung disease (ILD) (hereafter, RA‐ILD) and idiopathic pulmonary fibrosis, we hypothesized that the strongest risk factor for the development of ...
P. Juge, Joyce S. Lee, E. Ebstein, H. Furukawa, E. Dobrinskikh, S. Gazal, C. Kannengiesser, S. Ottaviani, S. Oka, S. Tohma, N. Tsuchiya, J. Rojas-Serrano, M. González-Pérez, M. Mejía, I. Buendía-Roldán, R. Falfán-Valencia, E. Ambrocio-Ortiz, E. Manali, S. Papiris, T. Karageorgas, D. Boumpas, K. Antoniou, C. V. van Moorsel, J. J. van der Vis, Y. D. de Man, J. Grutters, Yaping Wang, R. Borie, L. Wémeau-Stervinou, B. Wallaert, R. Flipo, H. Nunes, D. Valeyre, N. Saidenberg-Kermanac’h, M. Boissier, S. Marchand-Adam, A. Frazier, P. Richette, Y. Allanore, J. Sibilia, C. Dromer, C. Richez, T. Schaeverbeke, H. Lioté, G. Thabut, N. Nathan, S. Amselem, M. Soubrier, V. Cottin, A. Clément, K. Deane, A. Walts, T. Fingerlin, A. Fischer, J. Ryu, E. Matteson, T. Niewold, D. Assayag, A. Gross, P. Wolters, M. Schwarz, M. Holers, J. Solomon, T. Doyle, I. Rosas, C. Blauwendraat, M. Nalls, M. Debray, C. Boileau, B. Crestani, D. Schwartz, P. Dieudé   +71 more
semanticscholar   +1 more source